August 10, 2026

Revolution Medicines, Inc. (RVMD) Stock Analysis: A Biotech Powerhouse with a Bold Vision for Cancer Treatment

Revolution Medicines, Inc. (NASDAQ: RVMD) has emerged as a formidable player in the biotechnology sector, capturing the attention of investors with its pioneering approach to cancer..

Regencell Bioscience Holdings L (RGC) Stock Analysis: Navigating the Volatility in Hong Kong’s TCM Innovator

Regencell Bioscience Holdings L (NASDAQ: RGC) presents a unique opportunity for investors with an appetite for high-risk, high-reward investments in the healthcare sector. This Hong Kong-based..

Alkermes plc (ALKS) Stock Analysis: Evaluating a 13.89% Upside in the Biopharmaceutical Sector

Alkermes plc (NASDAQ: ALKS), a noteworthy player in the biopharmaceutical sector, is capturing investor attention with its robust portfolio of treatments and promising growth metrics. As..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: A 39% Upside Potential Backed by Robust Buy Ratings

iRhythm Holdings, Inc. (NASDAQ: IRTC), a leader in the healthcare sector specializing in medical devices, continues to capture investor interest with its innovative cardiac monitoring solutions...

Stevanato Group S.p.A. (STVN): Investor Outlook Reveals 23.83% Potential Upside

Stevanato Group S.p.A. (STVN), a key player in the healthcare sector specializing in medical instruments and supplies, is capturing investor attention with a market capitalization of..

Natera, Inc. (NTRA) Stock Analysis: Exploring the Bullish Analyst Consensus in the Diagnostics Sector

Natera, Inc. (NASDAQ: NTRA), a prominent player in the healthcare sector focusing on diagnostics and research, has caught the attention of investors with its impressive market..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating a 10.69% Upside Potential Amidst Revenue Challenges

Investors setting their sights on the healthcare sector might find Dr. Reddy’s Laboratories Ltd (RDY) an intriguing option, particularly with its projected 10.69% potential upside. As..

Tenet Healthcare Corporation (THC) Stock Analysis: A Promising 7.49% Upside Potential for Investors

Tenet Healthcare Corporation (NYSE: THC) is capturing the attention of investors with its robust market position in the healthcare sector. As a diversified healthcare services company,..

STERIS plc (STE) Stock Analysis: Navigating a 10% Upside Potential in the Medical Device Space

Investors looking to capitalize on opportunities in the healthcare sector might find STERIS plc (NYSE: STE) to be an intriguing prospect. With a market capitalization of..

Insmed Incorporated (INSM) Stock Analysis: A Biotech Powerhouse with a 52.80% Upside Potential

Insmed Incorporated (NASDAQ: INSM) is a formidable player in the biotechnology sector, demonstrating remarkable growth potential and attracting significant attention from investors and analysts alike. With..

Jazz Pharmaceuticals (JAZZ): Investor Outlook on a Biotech Powerhouse with a 9.51% Upside Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a notable player in the healthcare sector, is making waves in the biotechnology industry with its robust portfolio of pharmaceutical products..

ADMA Biologics Inc (ADMA): Investor Outlook Highlights 71.72% Potential Upside

ADMA Biologics Inc (NASDAQ: ADMA), a key player in the biotechnology sector, is drawing significant attention from investors with a compelling potential upside of 71.72%. With..

Nuvalent, Inc. (NUVL) Stock Analysis: Navigating Biotech’s Uncharted Waters with Zero Upside

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, stands at the forefront of innovation in cancer therapy development. Specializing in creating therapies..

Takeda Pharmaceutical Co. (TAK) Stock Analysis: Exploring a 22.88% Upside Potential

Takeda Pharmaceutical Company Limited (NYSE: TAK) stands as a significant player within the healthcare sector, operating in the niche domain of drug manufacturing, including both specialty..

Waystar Holding Corp. (WAY) Stock Analysis: Why Analysts See a 37% Upside Potential

Waystar Holding Corp. (NASDAQ: WAY) is making waves in the healthcare information services sector, capturing investor attention with a robust 37.45% potential upside according to recent..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating a 10.70% Upside Potential with Solid Revenue Growth

Henry Schein, Inc. (NASDAQ: HSIC), a prominent player in the healthcare sector, is capturing investor attention with its robust revenue growth and a potential upside of..

Cardinal Health (CAH) Stock Analysis: 6.77% Potential Upside Amid Robust Revenue Growth

Cardinal Health, Inc. (NYSE: CAH), a pivotal player in the healthcare sector, is capturing investor attention due to its promising potential upside and robust revenue growth...

HealthEquity, Inc. (HQY) Stock Analysis: Investor Optimism with 13% Upside Potential

HealthEquity, Inc. (NASDAQ: HQY), a prominent player in the healthcare sector, is drawing significant attention from investors with its robust service offerings and potential upside. With..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: A Promising 32.94% Upside in the Biotech Sector

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a noteworthy player in the biotechnology industry, is capturing investor attention with its promising potential for a 32.94% upside, as indicated..

ResMed Inc. (RMD) Stock Analysis: Unveiling a 16.64% Potential Upside in the Healthcare Sector

ResMed Inc. (NYSE: RMD) is a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $30.74..

Search

Funds

August 10, 2026

Search

Funds

August 10, 2026

FTSE 100

Funds